Discussion on the Use of Placebell and FDA’s Feedback
Cognivia recently initiated a discussion with the FDA through the “Innovative Science and Technology Approaches for New Drugs…
Cognivia recently initiated a discussion with the FDA through the “Innovative Science and Technology Approaches for New Drugs…
Cognivia is pleased to announce an upcoming webinar focused on strategies for aligning with the FDA’s recent draft…
Alternative and safe therapeutic approaches for neuropathic pain are needed. Interdisciplinary and collaborative research is essential to advance…
Cognivia is thrilled to announce the strategic expansion of its subsidiary, Cognivia USA Inc., into the US market….
Cognivia, an emerging leader in the drug development ecosystem, is committed to making a significant impact in the…
Cognivia, a global leader in providing ML-based digital solutions to address data variability in clinical research, is thrilled…